Innovation Pharmaceuticals Inc (IPIX)

[Longpicker]

My question to the panel:

There is a Covid-19 phase 2 trial starting soon for a therapeutic drug from Innovation Pharmaceuticals called Brilacidin. Laboratory testing has shown the drug to be 97% effective in killing the Sars Cov 2 virus while maintaining a very high safety profile. If that trial proves successful, will you work in conjunction with the FDAs fast tract designation of Brilacidin to get this drug to the people who need it most by granting doctors the ability to use it for compassionate use?